RecruitingNCT02122562
Brain imaging of ketamine response in treatment-resistant depression
About this title
Read the official source — NCT02122562Medication studyAges 18–55United States
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
What will I do during this study?
The study group receives ketamine as a study medication.
- Listed locations
- Iowa CitySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 23, 2014
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Mark Niciu
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02122562
- Official title
Show the full official title
Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Iowa City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mark Niciu.
Does this study involve medication?
Yes. The study involves medication, including ketamine.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
